Skip to main navigation Skip to search Skip to main content

Hydrogel versus bare platinum coils in patients with large or recurrent aneurysms prone to recurrence after endovascular treatment: A randomized controlled trial

  • J. Raymond
  • , R. Klink
  • , M. Chagnon
  • , S. L. Barnwell
  • , A. J. Evans
  • , J. Mocco
  • , B. H. Hoh
  • , A. S. Turk
  • , R. D. Turner
  • , H. Desal
  • , D. Fiorella
  • , S. Bracard
  • , A. Weill
  • , F. Guilbert
  • , S. Lanthier
  • , A. J. Fox
  • , T. E. Darsaut
  • , P. M. White
  • , D. Roy
  • Centre Hospitalier de L'Universite de Montreal
  • University of Montreal
  • Oregon Health and Science University
  • Icahn School of Medicine at Mount Sinai
  • University of Florida
  • Medical University of South Carolina
  • Centre Hospitalier Universitaire de Nantes
  • CHU de Nancy
  • University of Virginia
  • University of Toronto
  • University of Alberta
  • Newcastle University

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

Background and Purpose: Some patients are at high risk of aneurysm recurrence after endovascular treatment: patients with large aneurysms (Patients Prone to Recurrence After Endovascular Treatment PRET-1) or with aneurysms that have previously recurred after coiling (PRET-2). We aimed to establish whether the use of hydrogel coils improved efficacy outcomes compared with bare platinum coils. MATERIALS AND METHODS: PRET was an investigator-led, pragmatic, multicenter, parallel, randomized (1:1) trial. Randomized allocation was performed separately for patients in PRET-1 and PRET-2, by using a Web-based platform ensuring concealed allocation. The primary outcome was a composite of a residual/recurrent aneurysm, adjudicated by a blinded core laboratory, or retreatment, intracranial bleeding, or mass effect during the 18-month follow-up. Secondary outcomes included adverse events, mortality, and morbidity (mRS-2). The hypothesis was that hydrogel would decrease the primary outcome from 50% to 30% at 18 months, necessitating 125 patients per group (500 for PRET-1 and PRET-2). RESULTS: The trial was stopped once 250 patients in PRET-1 and 197 in PRET-2 had been recruited because of slow accrual. A poor primary outcome occurred in 44.4% (95% CI, 35.5%-53.2%) of those in PRET-1 allocated to platinum compared with 52.5% (95% CI, 43.4%-61.6%) of patients allocated to hydrogel (OR, 1.387; 95% CI, 0.838-2.295; P-.20) and in 49.0% (95% CI, 38.8%-59.1%) in PRET-2 allocated to platinum compared with 42.1% (95% CI, 32.0%-52.2%) allocated to hydrogel (OR, 0.959; 95% CI, 0.428-1.342; P-.34). Adverse events and morbidity were similar. There were 3.6% deaths (1.4% platinum, 5.9% hydrogel; P-.011). CONCLUSIONS: Coiling of large and recurrent aneurysms is safe but often poorly effective according to angiographic results. Hydrogel coiling was not shown to be better than platinum.

Original languageEnglish
Pages (from-to)432-441
Number of pages10
JournalAmerican Journal of Neuroradiology
Volume38
Issue number3
DOIs
StatePublished - Mar 2017

Fingerprint

Dive into the research topics of 'Hydrogel versus bare platinum coils in patients with large or recurrent aneurysms prone to recurrence after endovascular treatment: A randomized controlled trial'. Together they form a unique fingerprint.

Cite this